AAN

Follow-up data from TOPIC, CARE-MS II trials positive for the two MS drugs.

“This appears to be a very safe and effective drug, and is a valuable part of our therapeutic armamentarium. I don’t think teriflunomide addresses all the unmet needs in MS, in fact, no drug meets all the unmet needs, but this is a very well tolerated oral agent.”

The nearly 7-year extension trial presented a 47% reduction overall in conversion to clinically definite MS with those patients who had been on 14mg of teriflunomide from the beginning.

Ocrevus reduced all 3 aspects of relapsing MS disease: reduction relapses, reduction disability, and reduction lesions within the brain quite substantially.

Tecfidera and Tysabri can provide MS patients with positive outcomes.

“Unlikely to have clinically relevant interactions with any commonly prescribed AEDs.”

Patients with tardive dyskinesia were previously only looked at, not treated.

The treatment of tardive dyskinesia can improve the impact of the condition on these very complicated patients.

“When we make recommendations, we don’t just use the evidence from the studies.”

Study results coincide with FDA's recent decision on a stimulation device.

Kids with lower limb spasticity should be given Dysport.

Those treated experienced an average decrease of 2.9 monthly migraine days.

Researchers previously only considered ALS as one illness, but new knowledge has changed that mentality and has shown experts they need to personalize treatment approaches. “It’s important to understand the disease in different groups of people.”

Risk of death in epilepsy "almost the elephant in the room,” according to Donner.

"This is disease-specific, mechanism-based treatment," Amaal Starling enthuses.

Past studies of AF have under-represented women, according to Louise McCullough.

Preliminary results hint at a new type of progressive MS treatment.

Cannabidiol may cut the number of seizures for some patients who have epilepsy.

A battery-operated Liftware utensil was developed in 2014 to help Parkinson’s disease patients manage their hand tremors and conquer daily activities.

Older adults who suffer from sleep problems also experience reduced brain volume, new research finds.

Pregnant women who obtain treatment for acute migraine experience higher rates of preeclampsia, preterm delivery, and deliver babies with low birth-weight.

Athletes with psychosomatic symptoms or medical complaints like aches and pains without concrete physical causes can prolong recovery time after suffering a concussion.

A long held myth that epilepsy interferes with conception has been busted.

Whether it is learning from the military or finding consensus among the governing bodies of youth and scholastic sports there are steps that can be taken to make them safe and help limit the risk of injuries and concussions.

The issue of concussions and potential brain damage has made considerable headlines in recent years. What the cause and diagnosis of these issues are remain to be determined.

With a unique delivery method alemtuzumab, also known as Lemtrada has proven to be an effective treatment option for multiple sclerosis. While careful monitoring is required new data has shown benefits for the right patient population.

Susan Schneider Williams, spouse of the late Robin Williams spoke with MD Magazine about the several symptoms the actor presented up to a year before his death that made it difficult to diagnose what he was suffering from: Lewy Body Disease (LBD).

Researchers at the American Academy of Neurology’s 68th Annual Meeting reported analyses of the phase III trial of the investigational glucocorticoid (deflazacort/Marathon Pharmaceuticals), which was previously found to improve muscle strength in Duchenne Muscular Dystrophy (DMD) patients.

The American Academy of Neurology (AAN) has released revised guidelines for using botulinum toxin to treat spasticity, cervical dystonia, blepharospasm, and migraine headache.